WLLW Insider Trading

Insider Ownership Percentage: 24.34%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Willow Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Willow Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Willow Biosciences Share Price & Price History

Current Price: C$0.17
Price Change: +0.30 (1.20%)
As of 08/22/2025 12:00 AM ET

This chart shows the closing price history over time for WLLW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Willow Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/14/2024Travis DoupeSenior OfficerBuy49,500C$0.09C$4,207.50
11/29/2023Christopher Kenneth SavileDirectorBuy50,000C$0.08C$3,750.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Willow Biosciences (TSE:WLLW)

0.10% of Willow Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Willow Biosciences logo
Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.
Read More on Willow Biosciences

Today's Range

Now: C$0.17
Low: C$0.15
High: C$0.17

50 Day Range

MA: C$0.17
Low: C$0.17
High: C$0.17

52 Week Range

Now: C$0.17
Low: C$0.01
High: C$0.15

Volume

59,500 shs

Average Volume

626,457 shs

Market Capitalization

C$24.62 million

P/E Ratio

N/A

Dividend Yield

7.35%

Beta

1.13

Who are the company insiders with the largest holdings of Willow Biosciences?

Willow Biosciences' top insider shareholders include:
  1. Trevor Anthony Peters (Director)
  2. Travis Doupe (Senior Officer)
  3. Sadiq Lalani (Director)
  4. Christopher Kenneth Savile (Senior Officer)
  5. Peter Seufer-Wasserthal (Director)
  6. Christopher Kenneth Savile (Director)
Learn More about top insider investors at Willow Biosciences.